Oviva, a leading European provider of digital care for weight-related and chronic conditions, has secured USD 200M in a series D investment round led by Kinnevik with participation of various investors. This funding will be used to Oviva’s scale evidence-based, personalized care to many more people..

Oviva是一家领先的欧洲数字护理提供商，专注于体重相关和慢性疾病的护理，近日在由Kinnevik领投、多位投资者参与的D轮融资中筹集了2亿美元。这笔资金将用于扩大Oviva基于证据的个性化护理服务，惠及更多人群。

More than 200 million adults live with obesity and weight-related chronic conditions in Europe. Healthcare systems are strained. Significant clinician shortages and a lack of access to in-person care further exacerbate the issue. Kai Eberhardt and Manuel Baumann founded

欧洲有超过两亿成年人患有肥胖症和与体重相关的慢性疾病。医疗系统不堪重负。严重的临床医生短缺以及缺乏面对面的医疗服务进一步加剧了这一问题。Kai Eberhardt 和 Manuel Baumann 创立了

Oviva

欧维瓦

to address this challenge through an evidence-based, scalable, digital solution for chronic conditions well integrated within national reimbursement frameworks and physician workflows.

通过基于证据、可扩展、针对慢性病的数字解决方案来应对这一挑战，该方案能够很好地融入国家报销框架和医生工作流程。

Oviva offers a patient-facing interface with access to multidisciplinary care teams helping patients achieve sustainable, best-in-class outcomes. Its AI-enabled platform personalizes support for patients and allows clinicians to focus more on real patient impact and reaching more people. The programs are free of charge for patients given the company’s full reimbursement status in its core markets: Germany, the UK, and Switzerland..

Oviva 提供面向患者的界面，患者可以接触到多学科护理团队，帮助他们实现可持续的最佳效果。其支持人工智能的平台为患者提供个性化支持，让临床医生能够更专注于对患者的切实影响并覆盖更多人群。该公司在核心市场（德国、英国和瑞士）享有全额报销待遇，因此这些项目对患者免费提供。

To date, the company has supported more than one million patients to date and over the past two years, it has tripled new patient intake, and achieved cash-flow profitability in 2025, underscoring the scalability and durability of its product and business model. The effectiveness of Oviva’s programs is also proven by over 90 peer-reviewed studies..

迄今为止，该公司已经支持了超过一百万名患者，而且在过去两年中，新患者接诊量增加了三倍，并在2025年实现了现金流盈利，充分证明了其产品和商业模式的可扩展性与持久性。Oviva计划的有效性也得到了90多项同行评审研究的证实。

Kinnevik

金内维克

led Oviva’s USD 220m Series D round with a USD 100m investment, through a combination of primary and secondary capital. Kinnevik is now Oviva’s largest shareholder, joining a strong group of new long-term investors and existing backers, among them

通过一级和二级资本相结合的方式，领投了Oviva的2.2亿美元D轮融资，投资额为1亿美元。Kinnevik现在是Oviva的最大股东，加入了一群强大的新长期投资者和现有支持者行列，其中包扩

Temasek

淡马锡

and

和

Sofina

索菲娜

. Further participants in the series D round are

. D轮系列的其他参与者是

Planet First Partners

行星第一伙伴

,

，

A.P. Moller Holding

A.P. 穆勒控股公司

,

，

Lunate

月牙形的

,

，

EGS Beteiligungen AG

EGS 投资股份公司

,

，

Norrsken VC

诺斯肯风险投资公司

.  The financing will support Oviva in meeting growing demand, expanding into additional markets and chronic conditions such as high blood pressure and type 2 diabetes, as well as further advancing its AI-supported platform.

融资将支持Oviva满足不断增长的需求，扩展到更多市场和慢性病领域，如高血压和2型糖尿病，同时进一步推进其人工智能支持的平台。

Kinnevik’s Senior Investment Director, Christian Scherrer, said, “Obesity is a multi-billion-dollar challenge which costs European countries more than 1.5% of GDP each year. This is where Oviva presents a rare win-win-win opportunity: better patient outcomes, meaningful time savings for physicians, and lower costs along with productivity gains for health systems.

Kinnevik的高级投资总监Christian Scherrer表示：“肥胖问题是一个价值数十亿美元的挑战，每年使欧洲国家损失超过GDP的1.5%。而Oviva在此展现了难得的三赢机会：患者获得更好的治疗效果，医生节省宝贵时间，医疗系统则实现成本降低和生产力提升。”

Oviva has found an incredibly strong product market fit. Kai and Manuel have impressed us with their clinical rigor, disciplined execution at scale, and a genuine commitment to impacting patients and health systems for the better. We look forward to partnering with the entire Oviva team to realize their vision of becoming the European leader in virtual chronic care.”.

Oviva已经找到了一个非常强劲的产品市场契合点。Kai和Manuel以其临床严谨性、大规模的纪律执行以及对改善患者和健康系统的真诚承诺给我们留下了深刻印象。我们期待与整个Oviva团队合作，实现他们成为欧洲虚拟慢性护理领导者的愿景。"

(Press release/RAN)

（新闻稿/随机接入网络）

0

0

Comments

评论

Back to all news

返回所有新闻

Please

请

login

登录

or

或

sign up

注册

to comment.

评论。

Commenting guidelines

评论指南

Send

发送